International Conference on Intelligent Biology and Medicine
全文截稿: 2019-02-16
开会时间: 2019-06-09
会议难度: ★★
会议地点: Columbus, Ohio, USA
网址:http://icibm2019.org/
The 2019 International Conference on Intelligent Biology and Medicine (ICIBM 2019) will be held on June 9-11, 2019 in Columbus, OH, USA. You are invited to submit abstracts with unpublished original work describing recent advances on all aspects of bioinformatics, Systems Biology and intelligent Computing, including but not restricted to the following topics:
Cancer Genomics Metabolomics Microbiome/Metagenomics Translational pharmacoinformatics Omics Integration Medical Informatics Scientific databases Imaging informatics Systems Biology Algorithms/Artificial Intelligence Single-cell analysis
生物医学工程
BioNLP 2019
ACL Workshop on Biomedical Natural Language Processing
全文截稿: 2019-04-26
开会时间: 2019-08-01
会议难度: ★★
会议地点: Florence, Italy
网址:https://aclweb.org/aclwiki/BioNLP_Workshop
BIONLP 2019: An ACL 2019 Workshop associated with the SIGBIOMED special interest group and featuring an associated task: MEDIQA 2019 ( https://sites.google.com/view/mediqa2019) Florence, Italy, August 1, 2019
神经学
NeuroImage
Neuroscience of Creativity in NeuroImage
全文截稿: 2019-06-01
影响因子: 5.426
中科院JCR分区:
• 大类 : 医学 - 2区
• 小类 : 神经成像 - 1区
• 小类 : 神经科学 - 2区
• 小类 : 核医学 - 2区
网址: https://www.journals.elsevier.com/neuroimage
The creative ability of a human brain represents perhaps the highest cognitive reach of 3.8 billion years of evolution. Human creativity has widely recognized value for learning and practice in the arts and sciences, and as a driver of the modern innovation economy. Because creativity has such broad and diverse impacts, the neuroscience of creativity is being pursued by a diverse set of researchers. At this very early stage, disconnected efforts are being undertaken separately and haphazardly by researchers siloed within sub-disciplines of psychology, education, industry, and clinical neuroscience. For the neuroscience of creativity to fulfill its considerable potential, there is a critical need for greater communication and cohesion among stakeholders. Hence, using this Special Issue on the neuroscience of creativity, we hope to bring together both expository and new empirical work from many leading creativity neuroscience labs and highlight research priorities for the field. The aim is for this issue to provide a beacon that helps coalesce a growing field around promising directions in order to catalyze basic understanding of how creativity happens in the brain and how to enhance it. We plan to include in the Special Issue neuroimaging empirical research, brief opinions, perspectives, and review articles. Our goal will be for the majority (~75%) of articles to be empirical papers, with the remaining devoted to other formats.
Non-exhaustive list of relevant topics for the neuroscience/neural correlates of:
creative thinking
changes in state creativity
interventions (e.g., neuromodulation/training) associated with creativity
brain development and creativity
team creativity
musical creativity
artistic creativity
creative reasoning
imagination and creativity
aesthetic creativity
mental health and creative thinking
environmental factors on creative thinking
毒理学
Reproductive Toxicology
Translational Use of In Vitro- and In Silico-Based Developmental Toxicity Systems for Human Health Assessment
To assess the vast chemical space to which pregnant mothers are exposed, an integrated framework of multiple approaches, consisting ofin vitro– andin silico–based models, are needed to predict the complexity of human prenatal developmental toxicity. Global efforts are being made by multidisciplinary scientists across academia, industry and government, to develop these tools, and equally of importance, are compiling databases of legacyin vivotesting records and human chemical biomonitoring data for approach comparisons and to bridge towards risk assessment applications. An example of this includes the Integrated Approaches to Testing and Assessment (IATA) developed within the Organisation for Economic Co-operation and Development (OECD). This concept focuses on following an integrative approach to aggregate data of diverse forms (e.g.,QSARs, read-across, toxicogenomics,in vitro, andin vivo), to answer a specific question in a regulatory context. We are soliciting publications focused on translation of these approaches to risk assessment and reduce data gaps, with focus areas on exposure, hazard assessment, and risk. Specifically, articles may emphasize using a battery of approaches, anchoringin vitrodata toin vivoeffect, regulatory use cases, risk assessment frameworks, prenatal developmental toxicity focused databases, pregnant mother/fetal exposome monitoring, andin silicomodeling for broad chemical evaluation. Types of analyses may include (but are not limited to), adverse outcome pathways (AOPs), pharmacologically-based toxicokinetic modeling (PBTK), non-mammalian whole animal models, embryonic stem cells, QSAR modeling, read-across, toxicogenomics, high-throughput screening (HTS), high-content screening (HCS), and plasma concentration monitoringin vivo.